Verixa Dataset Tracker
π Patent-filing date realignment Β· 18 Jun β 26 Jun β 03 Jul 2026
Patent FD target shifted from 15 Jun 2026 to 26 Jun 2026 03 Jul 2026 . All FD+N statutory and decision dates shift accordingly: Β§39 clock starts 26 Jun 03 Jul Β· complete specifications due 26 Jun 2027 03 Jul 2027 (Β§9(1)) Β· PCT decision 26 Dec 2026 03 Jan 2027 Β· US/EU national-phase entry 26 Dec 2028 03 Jan 2029 Β· Request for Examination 26 Jan 2029 03 Feb 2029 . Marketing public-disclosure window also shifts: founder 1-to-1 outbound to known DP targets continues pre-FD under NDA; public marketing (newsletter Β· pillar pages Β· founder LinkedIn cadence Β· PR note Β· webinar invites) unlocks Mon 29 Jun 2026 Tue 07 Jul 2026 (W5) post-FD. Engineering W1-W14 pilot timeline holds: demo lock Fri 26 Jun Β· Verified Go-Live Decision Tue 01 Sep.
Two dataset bodies behind the demo & pilot verification: Synthetic Data Set (demo seed, advisory) + Gold-Standard / Validate corpus (real-world) Β· plan VRX-SDP-001 Β· the dataset + flow sent to the build/test team Β· development phase β advisory, no change control until verified, tested & validated
43
Synthetic datasets (v1.0)
5
locked Gold-Standard anchors
589k
FDA-483 narrative corpus rows
42
in-scope pilot workflows (25 AΒ·9 BΒ·4 CΒ·3 ext)
1.5 π‘
demo seed build item β open
Overview & Insights
Synthetic Data Set (43)
Gold-Standard & Real Corpus
Plan & Tiering (VRX-SDP-001)
Demo Scenario Data Set
Testing-Team Handoff
Governance
Advisory Β· ENGINEERING_VERIFICATION Β· NOT Gold Standard β synthetic data is never the system of record for any regulatory claim. Deterministic generators (same seed β SHA-256-identical, Gate G6) Β· 11 ALCOA+ provenance columns on 100% of rows. Development phase: advisory only, no change control until verified, tested & validated. Manifest build 2026-06-08 Β· sibling of the Verixa tracker family.